Posts in category All News
These 4 stocks showing RSI Trending Up on June 27 (28-06-2024)
According to data from stockedge.com on June 27, four stocks in the large-cap category were identified in the RSI Trending Up scan.
JSW Infrastructure announces acquisition of 70.37% stake in Navkar (28-06-2024)
Navkar is listed on BSE and NSE. It's key operating facilities are:
F&O Radar| Deploy Bull Call Spread in TCS to capitalize potential up-move (28-06-2024)
The stock then took support around the level of 3,650, from where it resumed the journey upwards and following a brief consolidation of a few sessions, the stock showed strength as a strong bullish candle was formed on Thursday.
Bharti Airtel revises mobile tariffs effective 3rd July (28-06-2024)
The company said, "We have ensured that there is a very modest price increase (less than 70p per day) on the entry level plans, in order to eliminate any burden on budget challenged consumers."
These 3 stocks close crossing below VWAP on June 27 (28-06-2024)
According to technical scan data from stockedge.com, on June 27, the closing prices of three stocks in Nifty200 fell more than 1% below the VWAP.
Want to balance risk-return now and not just focus on returns: Siddharth Vora (28-06-2024)
Other than valuations which seem to provide some sort of caution, volatility has come off very significantly post elections. All the macro data points around India are very robust. From a macro perspective, there are no major red flags. We are not seeing any major systemic risk for Indian equities as well andit is very clear that this is still a broad-based bull market, Siddharth Vora.
Initiating Coverage: Brokerage sees 10-26% upside in Coforge, Man Industries & Bandhan Bank (28-06-2024)
Emkay has initiated a buy rating on Man Industries with a target price of Rs 500, indicating a 26% upside from the current price of Rs 394.
Lupin to pay fine of Euro 40 million to European Commission (28-06-2024)
The patent settlement agreement entered into by the Company with Servier in January 2007 for the product Perindopril was found to be anticompetitive by the European Commission.